| 摘要 |
1. Use of a bacterial combination composition comprising as bacterial strains: (a) Streptococcus thermophilus in admixture with (b) at least one bacterial strain selected from the group consisting of Lactobacillus brevis, Lactobacillus acidophilus, Lactobacillus plantarurm, Bifidobacterium infantis, Bifidobacterium longum and Bifidobacterium brave or mixtures thereof, for preparing a dietary, pharmaceutical or veterinary composition for the prevention and/or treatment of hyperoxaluria and the disorders associated therewith. 2. The use of Claim 1, wherein the strain of Lactobacillus brevis is the strain of Lactobacillus brevis DSM 11988. 3. The use of claim 1, wherein the ratio of the concentrations of Bifidobacterium infantis, Bifidobacterium longum and Bifidobacterium breve in the mixture, expressed in CFU/g of composition, are 1:1:1. 4. The use of claims 1-2, wherein the ratio of the concentrations of Streptococcus thermophilus and the Lactobacillus strain, expressed in CFU/g of composition, is from 1000:1 to 1:1000. 5. The use of claim 1, wherein the ratio of the concentrations of Streptococcus thermophilus and the Bifidobacterium strain, expressed in CFU/g of composition, is from 1000:1 to 1:1000. 6. A method for the prevention and/or treatment of hyperoxaluria and the disorders associated therewith which comprises administering to an animal in need thereof from 0.5 to 4 g/die of a bacterial combination composition comprising: (a) Streptococcus thermophilus in admixture with (b) at least one bacterial strain selected from the group consisting of Lactobacillus brevis, Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium infantis, Bifidobacterium longum and Bifidobacterium breve or mixtures thereof. |
